Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now?
Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap small cap stocks to buy now. Nortiva Bio, Inc., which is a wholly owned subsidiary of Innoviva, Inc.
Innoviva Inc. (INVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 4,036,532 | $91,669,642 | -1% | 0.13% |
| 2. | Millennium Management Israel Englander | 2,541,109 | $57,708,585 | +12% | 0.02% |
| 3. | Sarissa Capital Management Alex Denner | 1,890,604 | $42,935,617 | -12% | 24.14% |
| 4. | 36,000,000 | $38,730,778 | +95% | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,454,319 | $33,027,585 | -4% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.13 | 62,000 | $814,196.40 | 7,277,000 | 2023-06-15 | Filing | |
| $13.05 | 8,000 | $104,384.00 | 7,215,000 | 2023-06-06 | Filing | |
| $13.04 | 7,000 | $91,296.80 | 7,207,000 | 2023-06-05 | Filing | |
| $13.01 | 120,000 | $1,560,648.00 | 7,200,000 | 2023-05-30 | Filing | |
| $13.12 | 30,000 | $393,729.00 | 7,080,000 | 2023-05-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.52 | 1,196,746 | $20,964,237.40 | 5,658,705 | 2025-03-06 | Filing | |
| $17.63 | 270,374 | $4,766,125.83 | 6,855,451 | 2025-03-05 | Filing | |
| $17.63 | 151,175 | $2,665,079.19 | 7,125,825 | 2025-03-04 | Filing | |
| $13.97 | 5,405 | $75,507.85 | 40,158 | 2023-11-15 | Filing | |
| $14.01 | 5,589 | $78,301.89 | 45,563 | 2023-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,555,209 | $262,418,797 | 0% | |
| 2. | 4,494,053 | $102,062,559 | 0.02% | |
| 3. | 4,220,273 | $95,842,400 | 0% | |
| 4. | 3,268,004 | $74,216,371 | 0% | |
| 5. | 3,158,053 | $71,719,384 | 0% |
News See All
10 Cheap Small Cap Stocks to Buy Now
He talked about how he believes in FEMO, which stands for Fabulous Earnings Momentum, and stated that he has been bullish enough on earnings as we have had "fabulous earnings momentum".
Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform
TheFly reported on June 18 that INVA announced the launch of Nortiva Bio, a clinical-stage biopharmaceutical company focused on developing long-acting oral therapies through its proprietary LYNX drug ...
10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds
Tom Lee of Fundstrat spoke on CNBC's Closing Bell on June 9 about chip stocks, market mood, and the overall picture for stocks.
10 Most Profitable Undervalued Stocks to Invest In
On June 18, Kelsey Berro, JPMorgan Asset Management Fixed Income Portfolio Manager, appeared on CNBC's 'Squawk Box' to explain the market's reaction to the Fed's recent monetary policy decisions and the...
10 Best Small-Cap Value Stocks to Buy
Small-cap stocks are the real thing in an equity market under immense pressure amid geopolitical and monetary policy uncertainties.
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 - Here's Why
Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap biotech stocks to buy now. Cantor Fitzgerald lifted the price target on Innoviva, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Innoviva, Inc. (INVA): A Bull Case Theory
We came across a bullish thesis on Innoviva, Inc on Deep-Value Stocks’s Substack. In this article, we will summarize the bulls’ thesis on INVA.
H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating
Innoviva, Inc. (NASDAQ:INVA) is one of the best small cap stocks to buy with huge upside potential. Innoviva, Inc. (NASDAQ:INVA) received a rating update from H.C.
Hedge Fund Resource Center